1.
Chronic ulcerative colitis and colorectal cancer
by Rogler, Gerhard
Cancer letters, 2013, Vol.345 (2), p.235-241
2.
Guidelines for the management of inflammatory bowel disease in adults
by Mowat, Craig
Gut, 2011, Vol.60 (5), p.571-607
3.
4.
Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
by Charpentier, Cloé
Gut, 2014, Vol.63 (3), p.423-432
5.
Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011
by Rungoe, Christine
Gut, 2014, Vol.63 (10), p.1607-1616
6.
Systematic review: outcomes and post‐operative complications following colectomy for ulcerative colitis
by Peyrin‐Biroulet, L.
Alimentary pharmacology & therapeutics, 2016, Vol.44 (8), p.807-816
7.
Nationwide prevalence of inflammatory bowel disease in Sweden: a population‐based register study
by Büsch, K.
Alimentary pharmacology & therapeutics, 2014, Vol.39 (1), p.57-68
8.
Systematic review with meta‐analysis: the effect of tobacco smoking on the natural history of ulcerative colitis
by To, N.
Alimentary pharmacology & therapeutics, 2016, Vol.44 (2), p.117-126
9.
Predicting outcome in acute severe ulcerative colitis: comparison of the Travis and Ho scores using UK IBD audit data
by Lynch, R. W.
Alimentary pharmacology & therapeutics, 2016, Vol.43 (11), p.1132-1141
10.
The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti‐TNF use: a time‐trend study
by Reich, K. M.
Alimentary pharmacology & therapeutics, 2014, Vol.40 (6), p.629-638
11.
Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit
by Lynch, R. W.
Alimentary pharmacology & therapeutics, 2013, Vol.38 (8), p.935-945
12.
Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients
by Iborra, Marisa
Journal of gastroenterology, 2016, Vol.52 (7), p.788-799
13.
Guidelines for the management of inflammatory bowel disease in adults
by Carter, M J
Gut, 2004, Vol.53 (suppl 5), p.v1-v16
14.
Psychiatric co‐morbidity is associated with increased risk of surgery in Crohn's disease
by Ananthakrishnan, A. N.
Alimentary pharmacology & therapeutics, 2013, Vol.37 (4), p.445-454
15.
Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis
by Lunney, P. C.
Alimentary pharmacology & therapeutics, 2015, Vol.42 (1), p.61-70
16.
Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study
by Gustavsson, A.
Alimentary pharmacology & therapeutics, 2010, Vol.32 (8), p.984-989
17.
Impact of early thiopurines on surgery in 2770 children and young people diagnosed with inflammatory bowel disease: a national population‐based study
by Chhaya, V.
Alimentary pharmacology & therapeutics, 2015, Vol.42 (8), p.990-999
18.
The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis
by Tyler, Andrea D
Gut, 2013, Vol.62 (10), p.1433-1439
19.
Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis
by Murthy, S. K.
Alimentary pharmacology & therapeutics, 2012, Vol.36 (11-12), p.1032-1039
20.
Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation
by Limketkai, B. N.
Alimentary pharmacology & therapeutics, 2014, Vol.40 (5), p.508-517
